ID: ALA4215522

Max Phase: Preclinical

Molecular Formula: C36H62O7

Molecular Weight: 606.89

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](CCCC(C)(C)O[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3

Standard InChI:  InChI=1S/C36H62O7/c1-21(10-9-16-32(2,3)43-31-30(41)29(40)28(39)25(20-37)42-31)22-13-18-36(8)24-11-12-26-33(4,5)27(38)15-17-34(26,6)23(24)14-19-35(22,36)7/h21-22,25-31,37-41H,9-20H2,1-8H3/t21-,22-,25+,26+,27+,28+,29-,30+,31-,34-,35-,36+/m1/s1

Standard InChI Key:  OWCNLTYIGPCQRC-CCWQIZJVSA-N

Associated Targets(Human)

Alpha-crystallin B chain 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 606.89Molecular Weight (Monoisotopic): 606.4496AlogP: 5.50#Rotatable Bonds: 8
Polar Surface Area: 119.61Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.21CX Basic pKa: CX LogP: 4.87CX LogD: 4.87
Aromatic Rings: 0Heavy Atoms: 43QED Weighted: 0.23Np Likeness Score: 2.87

References

1. Yang X, Chen XJ, Yang Z, Xi YB, Wang L, Wu Y, Yan YB, Rao Y..  (2018)  Synthesis, Evaluation, and Structure-Activity Relationship Study of Lanosterol Derivatives To Reverse Mutant-Crystallin-Induced Protein Aggregation.,  61  (19): [PMID:30153006] [10.1021/acs.jmedchem.8b00705]

Source